Human phagocytic cell responses to Scedosporium prolificans

References

• Salkin IF, McGinnis MR, Dykstra MJ, Rinaldi MG. Scedospor-ium inflatum, an emerging pathogen. J Gun Microbiol 1988; 26: 498–503.
   Web of Science ®Google Scholar
• Wood GM, McCormack JG, Muir DB, etal. Clinical features of infection with Scedosporium inflatum. Clin Infect Dis 1992; 14: 1027–1033.
   PubMed Web of Science ®Google Scholar
• Berenguer J, Rodriguez-Tudela JL, Richard C, et al. Deep infections caused by Scedosporium prolificans. Medicine 1997; 76: 256–265.
   PubMed Web of Science ®Google Scholar
• Bouza E, Muiioz P, Vega L, Rodriguez-Creixems M, Berenguer J, Escudero A. Clinical resolution of Scedosporium prolificans fungaemia associated with reversal of neutropenia following administration of granulocyte colony-stimulating factor. Clin Infect Dis 1996; 23: 192–193.
   Google Scholar
• Mann J, Sanz MA, Sanz GF, et al. Disseminated Scedosporium inflatum infection in a patient with acute myeloblastic leukemia. Eur J Clin Microbiol Infect Dis 1991; 10: 759–761.
   PubMed Web of Science ®Google Scholar
• Rabodonirina M, Paulus S, Thevenet F, et al. Disseminated Scedosporium prolificans infection after single lung transplanta-tion. Clin Infect Dis 1994; 19: 138–142.
   PubMed Web of Science ®Google Scholar
• Tadros TS, Workowski KA, Siegel RJ, Hunter S, Schartz DA. Pathology of hyalohyphomycosis caused by Scedosporium apiospermum (Pseudallescheria boydii): an emerging mycosis. Hum Pathol 1998; 29: 1266–1272.
   Google Scholar
• Tapia M, Richard C, Baro J, et al. Scedosporium inflatum infection in immunocompromised haematological patients. Br J Haemato11994; 87: 212–214.
   PubMed Web of Science ®Google Scholar
• Hopwood V, Evans EGV, Matthews J, Denning DW. Scedos-porium prolificans, a multi-resistant fungus, from a UK AIDS patient. J Infect 1995; 30: 153–155.
   PubMedGoogle Scholar
• Diamond RD, Clark RA. Damage to Aspergillus fumigatus and Rhizopus otyzae hyphae by oxidative and nonoxidative micro-bicidal products of human neutrophils in vitro. Infect Immun 1982; 38: 487–495.
   PubMed Web of Science ®Google Scholar
• Roilides E, Katsifa H, Walsh T. Pulmonary host defenses against Aspergillus fumigatus. Res Immunol 1998; 149: 454–465.
   Google Scholar
• Schaffner A, Douglas H, Braude A. Selective protection against conidia by mononuclear and against mycelia by polymorpho-nuclear phagocytes in resistance to Aspergillus. J ain Invest 1982; 69: 617–631.
   Google Scholar
• Waldorf AR, Levitz SM, Diamond RD. In vivo bronchoalveolar macrophage defense against Rhizopus oryzae and Aspergillus fumigatus. J Infect Dis 1984; 150:752–760.
   Google Scholar
• Waldorf AR. Pulmonary defense mechanisms against opportu-nistic fungal pathogens. Immunol Ser 1989; 47: 243–271.
   PubMedGoogle Scholar
• Washburn RG, Gallin JI, Bennett JE. Oxidative killing of Aspergillus fumigatus proceeds by parallel myeloperoxidase-dependent and -independent pathways. Infect Immun 1987; 55: 2088–2092.
   Google Scholar
• Roilides E, Dimitriadou A, Kadiltsoglou I, et al. IL-10 exerts suppressive and enhancing effects on antifungal activity of mononuclear phagocytes against Aspergillus fumigatus. J Immunol 1997; 158: 322–329.
   PubMed Web of Science ®Google Scholar
• Roilides E, Dimitriadou A, Sein T, Kadiltsoglou I, Walsh TJ. Tumor necrosis factor alpha enhances antifungal activities of polymorphonuclear and mononuclear phagocytes against As-pergillus fumigatus. Infect Immun 1998; 66: 5999–6003.
   Google Scholar
• National Committee for Clinical Laboratory Standards. Refer-ence method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi; proposed standard, M38-P. Villanova, PA: National Committee for Clinical Laboratory Standards, 1998.
   Google Scholar
• Gosbell B3, Morris ML, Gallo JH, et al. Clinical, pathologic and epidemiologic features of infection with Scedosporium prolifi-cans: four cases and review. ain Microbiol Infect 1999; 5: 672–686.
   Google Scholar
• Gillian M, Wood JG, McCormack DB, etal. Clinical features of human infection with Scedosporium inflatum. ain Infect Dis 1992; 14: 1027–1033.
   Google Scholar
• Roilides E, Dignani MC, Anaissie EJ, Rex JH. The role of immunoreconstitution in the management of refractory oppor-tunistic fungal infections. Med Mycol 1998; 36 (Suppl. 1): 12–25.
   Google Scholar
• Gil-Lamaignere C, Rodriguez-Tudela JL, Roilides E. Effects of interferon-gamma (IFN-y ) and granulocyte-macrophage col-ony-stimulating factor (GM-CSF) on human phagocytic re-sponses to Scedosporium prolificans. Proceedings and abstracts of the 11th International Symposium on Infections in the Immunocompromised Patients, Halifax, June 2000. Halifax, Nova Scotia: International Immunocompromised Host Society, 2000: Abstract 072.
   Google Scholar